|
C14ORF147 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.619100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.841160E-04 |
| Normal-vs-Stage2 |
5.215700E-04 |
| Normal-vs-Stage3 |
1.120840E-01 |
| Normal-vs-Stage4 |
3.761500E-02 |
| Stage1-vs-Stage2 |
6.429600E-01 |
| Stage1-vs-Stage3 |
2.815800E-01 |
| Stage1-vs-Stage4 |
8.189800E-01 |
| Stage2-vs-Stage3 |
1.988980E-01 |
| Stage2-vs-Stage4 |
5.403200E-01 |
| Stage3-vs-Stage4 |
6.536000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.59580000003157E-06 |
| Normal-vs-AfricanAmerican |
1.170560E-01 |
| Normal-vs-Asian |
4.151200E-01 |
| Caucasian-vs-AfricanAmerican |
4.882400E-02 |
| Caucasian-vs-Asian |
1.847620E-01 |
| AfricanAmerican-vs-Asian |
9.087600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.67979999998735E-06 |
| Normal-vs-Female |
1.889030E-01 |
| Male-vs-Female |
2.558400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.578800E-04 |
| Normal-vs-Extreme_Weight |
1.75379999967085E-07 |
| Normal-vs-Obese |
3.569600E-02 |
| Normal-vs-Extreme_Obese |
5.572000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.888400E-01 |
| Normal_Weight-vs-Obese |
1.294200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.556400E-01 |
| Extreme_Weight-vs-Obese |
7.456300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.465400E-01 |
| Obese-vs-Extreme_Obese |
8.044000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.156000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.918680E-03 |
| Normal-vs-Age(61-80Yrs) |
2.376100E-04 |
| Normal-vs-Age(81-100Yrs) |
1.195080E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.752300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.545500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.777500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.885400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.607410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.492000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.04450000005497E-07 |
| Normal-VS-Type2 PRCC |
6.752300E-04 |
| Normal-VS-KIRP CIMP |
4.503600E-01 |
| Normal-VS-Unclassified PRCC |
6.595300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.461800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.379900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.805800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.455710E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.736000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.041700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.7027999999919E-05 |
| Normal-vs-N1 |
3.162800E-01 |
| Normal-vs-N2 |
7.698900E-03 |
| N0-vs-N1 |
4.708000E-02 |
| N0-vs-N2 |
4.831400E-01 |
| N1-vs-N2 |
1.796370E-01 |
|
|
